Rubicon Research Limited
Axis Mutual Fund bought 903,611 shares of Rubicon Research Limited for ₹150.00 Cr at ₹1660.00 apiece in a block deal.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
Subsidiary of Axis Bank, India's third-largest private sector bank. Manages over Rs 3.5 lakh crore in AUM. Built its brand on a quality growth equity philosophy with concentrated high-conviction portfolios. Flagship Axis Flexi Cap and Axis Bluechip funds are widely held among retail investors and drove significant AUM growth through the 2017-2021 bull cycle.